Detailed Information on Publication Record
2021
The Role of ATRA, Natural Ligand of Retinoic Acid Receptors, on EMT-Related Proteins in Breast Cancer: Minireview
BOBÁĽ, Pavel, M. LASTOVICKOVA and J. BOBALOVABasic information
Original name
The Role of ATRA, Natural Ligand of Retinoic Acid Receptors, on EMT-Related Proteins in Breast Cancer: Minireview
Authors
BOBÁĽ, Pavel (703 Slovakia, belonging to the institution), M. LASTOVICKOVA and J. BOBALOVA (guarantor)
Edition
International Journal of Molecular Sciences, Basel, Multidisciplinary Digital Publishing Institute, 2021, 1422-0067
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30104 Pharmacology and pharmacy
Country of publisher
Switzerland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 6.208
RIV identification code
RIV/00216224:14160/21:00124008
Organization unit
Faculty of Pharmacy
UT WoS
000738236600001
Keywords in English
breast cancer; EMT; protein; ATRA
Tags
International impact, Reviewed
Změněno: 31/1/2022 15:47, JUDr. Sabina Krejčiříková
Abstract
V originále
The knowledge of the structure, function, and abundance of specific proteins related to the EMT process is essential for developing effective diagnostic approaches to cancer with the perspective of diagnosis and therapy of malignancies. The success of all-trans retinoic acid (ATRA) differentiation therapy in acute promyelocytic leukemia has stimulated studies in the treatment of other tumors with ATRA. This review will discuss the impact of ATRA use, emphasizing epithelial-mesenchymal transition (EMT) proteins in breast cancer, of which metastasis and recurrence are major causes of death.
Links
MUNI/A/1682/2020, interní kód MU |
|